Myomo Inc. (MYO) is an Industrial Specialties company listed on AMEX. In the last 30 days Quantisnow tracked 16 wire items for MYO, including 8 insider trades, 4 SEC filings and 2 press releases and news items. The most recent was published Nov 9, 2026.
MYO rankings
Financial highlights
Full financials- Revenue, TTM
- $45.50M
- Revenue growth
- +9.3%
- Net income, TTM
- -$15.08M
- Net margin
- -33.1%
- Free cash flow, TTM
- -$7.20M
- Cash
- $11.10M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks56-45%
2026-05-172026-11-08
Mix2190d
- Insider11(52%)
- SEC Filings4(19%)
- Other3(14%)
- Earnings2(10%)
- Leadership1(5%)
Activity · 52 weeks9245 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 10-Q filed by Myomo Inc.10-Q - MYOMO, INC. (0001369290) (Filer)
- SECMyomo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Reports Third Quarter 2026 Financial and Operating ResultsRecord revenue of $12.3 million, increased 22% year over year Progress on four success pillars, including 54% of revenue from recurring patient sources Narrowing full-year revenue guidance to $46-47 million, at the upper end of previous guidance Conference call begins at 4:30pm Eastern time today Myomo, Inc. (NYSE:MYO)("Myomo" or the "Company"), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2026. "The focus on our four success pillars helped deliver record revenue and solid operating leverage in th
- PRMyomo to Attend the 17th Annual Craig Hallum Alpha Select ConferenceMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the 17th Annual Craig Hallum Alpha Select Conference being held Tuesday, November 17, 2026, at the Sheraton New York Times Square Hotel. Myomo’s President and Chief Executive Officer Paul Gudonis, Chief Financial Officer David Henry and Chief Commercial Officer Katie McClure will participate in one-on-one meetings throughout the event. Investors interested in scheduling a meeting with the Company should contact their Craig Hallum representative. About Myomo
- PRMyomo to Report Third Quarter 2026 Financial Results on November 9Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after the market close. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including
- PRPRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy MonthOrthoPediatrics, Omada Health, Enovis, Myomo and FIGS span the full arc of physical therapy, from childhood care and prevention to recovery and the professionals who deliver it NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView, a financial media platform covering small and micro-cap public companies, today published a feature marking National Physical Therapy Month. This year’s theme from the American Physical Therapy Association, "PT For Future Me," focuses on building strength, mobility and resilience across a lifetime to extend health span, the years people spend healthy and free of preventable chronic disease. PRISM’s feature highlights five public companies working on di
- INSIDERSEC Form 4 filed by Myomo Inc.4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERAmendment: SEC Form 4/A filed by Myomo Inc.4/A - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 4 filed by Myomo Inc.4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 4 filed by Myomo Inc.4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 4 filed by Myomo Inc.4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 4 filed by Myomo Inc.4 - MYOMO, INC. (0001369290) (Issuer)
- SECSEC Form 144 filed by Myomo Inc.144 - MYOMO, INC. (0001369290) (Subject)
- INSIDERSEC Form 4 filed by Myomo Inc.4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 3 filed by Myomo Inc.3 - MYOMO, INC. (0001369290) (Issuer)
- SECSEC Form S-8 filed by Myomo Inc.S-8 - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Appoints Mary-Katherine McClure as Chief Commercial OfficerMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Mary-Katherine ("Katie") McClure as Chief Commercial Officer effective October 12, 2026, succeeding Micah Mitchell, who will be departing following a leadership transition period. Ms. McClure brings more than 20 years of experience in transforming innovative medical technologies into sustainable commercial growth through strategic leadership, talent development, physician engagement, and enterprise partnerships. Ms. McClure joins Myomo from Inspire Medical Syst
- INSIDERChief Medical Officer Kovelman Harry sold $19,684 worth of shares (15,488 units at $1.27), decreasing direct ownership by 15% to 90,245 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- PRMyomo to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 at the Lotte Palace Hotel in New York. Myomo’s President and Chief Executive Officer Paul Gudonis and Chief Financial Officer David Henry will deliver a Company presentation and participate in one-on-one meetings throughout the event.Beginning Friday, September 11, 2026 at 7:00 a.m. ET, the formal presentation will be available on demand hereOn Wednesday, September 16,
- INSIDERAmendment: Chief Medical Officer Kovelman Harry sold $30,329 worth of shares (17,500 units at $1.73), decreasing direct ownership by 14% to 105,733 units (SEC Form 4)4/A - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Medical Officer Kovelman Harry sold $29,896 worth of shares (17,250 units at $1.73), decreasing direct ownership by 14% to 105,983 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Medical Officer Kovelman Harry covered exercise/tax liability with 22,457 shares and was granted 55,149 shares, increasing direct ownership by 36% to 123,233 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Commercial Officer Mitchell Micah was granted 58,409 shares and covered exercise/tax liability with 21,559 shares, increasing direct ownership by 39% to 130,738 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Executive Officer Gudonis Paul R was granted 146,909 shares, increasing direct ownership by 11% to 1,434,679 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Financial Officer Henry David A was granted 68,644 shares and covered exercise/tax liability with 25,310 shares, increasing direct ownership by 10% to 470,163 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
MYO FAQ
11 questionsWhat does Myomo Inc. do?
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The...What is the latest news on MYO?
In the last 30 days Quantisnow tracked 16 wire items for MYO: 8 insider trades, 4 SEC filings, 2 press releases and news items and 2 earnings updates. The most recent was published on November 9, 2026.What is MYO revenue?
Myomo Inc. (MYO) reported $45.50M of revenue for the twelve months ended Sep 30, 2026. That is up 9.3% from the year before. Revenue for fiscal 2025 was $40.93M.Is MYO profitable?
No. Myomo Inc. reported a net loss of $15.08M for the twelve months ended Sep 30, 2026.How much cash and debt does MYO have?
Myomo Inc. reported $11.10M in cash and cash equivalents and $11.65M of debt on its most recent balance sheet in SEC filings.Where does MYO stock trade?
Myomo Inc. (MYO) is listed on AMEX.What sector and industry is MYO in?
Myomo Inc. operates in the Health Care sector, Industrial Specialties industry.When did Myomo Inc. go public?
Myomo Inc. (MYO) completed its IPO in 2017.What are analysts saying about MYO?
Myomo Inc. has had 3 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $7.00 price target on 2024-07-31. Recent price targets range from $6.50 to $7.00.What companies are similar to MYO?
Notable peers in the same industry include ALGN (Align Technology Inc.), ZBH (Zimmer Biomet Holdings Inc.), STE (STERIS plc (Ireland)), EW (Edwards Lifesciences Corporation), ISRG (Intuitive Surgical Inc.). Compare MYO side-by-side with any of them on Quantisnow.How can I track MYO on Quantisnow?
Quantisnow aggregates Myomo Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MYO to receive live email and push alerts on every new disclosure.